Emerging evidence demonstrated that the aberrant activation of PI3K/AKT/mTOR pathway could modulate epithelial-mesenchymal transition, autophagy, chemoresistance and metastasis in several human cancers [17, 37–39]. The gene discussed is MTOR; the disease is cancer.